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Several radiological and endoscopic techniques are now available for the study of inﬂammatory bowel diseases. In everyday
practice, the choice of the technique to be used depends upon its availability and a careful evaluation of diagnostic accuracy,
clinical usefulness, safety, and cost. The recent development of innovative and noninvasive imaging techniques has led to a new
and exciting area in the exploration of the gastrointestinal tract, especially in Crohn’s disease patients by using ultrasound with
oral or intravenous contrast.
1.Introduction
The diagnosis of Crohn’s disease (CD) is based on clinical,
endoscopic, radiological, and histological criteria. The main
innovations in diagnostic technologies include the devel-
opment of more sophisticated endoscopic and noninvasive
imaging techniques with the aim of improving the identiﬁ-
cation of complications. Noninvasive tests for the diagnosis
and followup of CD have gained increasing attention. Rapid
and inexpensive noninvasive tests that are sensitive, speciﬁc,
and simple to perform are necessary to prevent patient
discomfort, delay in diagnosis, and unnecessary costs.
The use of transabdominal ultrasound (US) to evaluate
gastrointestinal (GI) tract disorders is used primarily in the
assessment of acute and chronic inﬂammatory conditions
such as appendicitis, diverticulitis, ulcerative colitis, and CD
[1]. Over the past few years, the technical evolution of
ultrasound equipment, combined with the use of oral and
intravenous contrast agents and the increased expertise of
the operators, has led to a great enthusiasm for ultrasound
assessment of the GI tract [2]. In chronic inﬂammatory
conditions, mainly CD, these properties have not only been
employedfordiagnosticpurposesbutalsobeenproposedfor
management and followup of the disease and its complica-
tions [3–7].
Bowel US has been largely promoted in continental
Europe, where ultrasonography is carried out by a physician
and is an integral part of the training curriculum for internal
medicine, gastroenterology, surgery, and other ﬁelds. This
technique is available in most European centers due to this
training curriculum, whereas its use is less widespread in the
United States.
2.CD Diagnosis
Bowel U.S. is now becoming the ﬁrst-line imaging procedure
in patients with suspected CD for early diagnosis of the
disease [8]. Several studies have evaluated the signiﬁcance of
the U.S. detection of bowel wall thickness in the diagnosis
of CD. Prospective studies, performed in unselected groups
of patients, have shown that bowel U.S. may diagnose CD
with a sensitivity ranging from 67–96% and speciﬁcity
ranging from 79–100% [9–18]. Most of the results were
obtained from studies that included patients with a previous
diagnosis of CD but lacked of a control population; thus, it is
diﬃcult to achieve a comprehensive evaluation of sensitivity
and speciﬁcity of the U.S. technique. These methodological
problems were evaluated by Fraquelli and Conte [19]. In
their meta-analysis, in which only ﬁve case-control and two
cohort studies were ultimately considered from an initial
44 full-text studies identiﬁed, the impact of diﬀerent cut-
oﬀ values of bowel wall thickening (3mm versus 4mm) in
determining the presence of CD was evaluated. The authors
concluded that, using a cutoﬀ level of 3mm as normal,
sensitivity and speciﬁcity were 88% and 93%, respectively.2 International Journal of Inﬂammation
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Figure 1: Small intestine contrast ultrasonography in a 20-year-old female with Crohn’s disease. In each panel ((a)–(d)) white arrows
indicate disease extent of the terminal ileum. The cumulative extent of the sonographic Crohn’s disease lesion was 26 cm. In (a), on the left
side, red arrow indicates bowel wall thickness (5.3mm) of the terminal ileum and in (b) (on the left side) and (d) green (both right and left
sides) arrows indicate lumen diameter (raging from 8 to 22mm) at level of the terminal ileum.
In contrast, when a cutoﬀ level of ≥4mm was used, the
sensitivity was 75% and speciﬁcity 97%. The meta-analysis
conducted by Horsthuis et al. evaluated the relevance of
US in the detection of IBD in comparison with other
techniques [20]. No signiﬁcant diﬀerences in diagnostic
accuracy among the imaging techniques were observed. The
authors concluded that because patients with IBD often
needed frequent reevaluation of disease status, use of a
diagnostic modality that does not involve the use of ionizing
radiation is preferable [20]. However, the results also show
that bowel US may, even in expert hands, be compounded
by false-positive and false-negative ﬁndings. Thickening of
the bowel walls is not speciﬁc for CD, also being present in
infectious, neoplastic, and other inﬂammatory diseases [21].
Bowel US may also provide false-negative results, even in
the hands of experienced ultrasonographers, for example,
in obese patients or those with anorectal lesions only, or
when the bowel disease is characterized by only superﬁcial
lesions, such as rare aphthous ulcers or mucosal erosions
[22]. Interobserver agreement between sonographers with
variable experience in bowel ultrasound has been reported
in a few preliminary studies showing satisfactory results, but
a learning curve for this technique is still lacking [14, 23].
This is probably one of the main reasons why bowel US is,
in clinical practice, still regarded with skepticism by many
clinicians and radiologists [6, 23].
The use of oral contrast agents such as iso-osmolar
polyethylene glycol solution (PEG; at a volume ranging
from 375–800mL) during ultrasound assessment has been
proposed to deﬁne CD lesions with improved accuracy
[24–26]( Figure 1). Because of the small amount of ﬂuid
ingested (usually no more than 500mL) and its palatability,
this procedure has been reported to be wellaccepted and
safe. None of the studies have reported signiﬁcant side
eﬀects or major complaints during or immediately after PEG
ingestion. The use of PEG appears to reduce intraobserver
variability between sonographers and to increase sensitivity
in deﬁning disease extent, lesion site, and bowel complica-
tionsofCD;thus,ithasvalueintheearlydiagnosisandinthe
followup of CD [26, 27]. These ﬁndings suggest that small
intestine contrast ultrasonography (SICUS) may be used as
an alternative technique to invasive procedures to assess ileal
lesions and monitor their progression over time.
3. Stenosis
B o w e lU Sc u r r e n t l yd e t e c t ss t e n o s i si n7 0 – 7 9 %o fu n s e l e c t e d
CD patients and in >90% of those with severe bowel stenoses
needing surgery, with false-positive diagnoses limited to 7%
[3, 4, 27, 28]. The use of PEG leads to a signiﬁcantly greater
accuracy of bowel ultrasound in detecting the presence andInternational Journal of Inﬂammation 3
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Figure 2: A 30-year-old male with stricturing Crohn’s disease assessed by bowel ultrasound (without oral contrast) (a) and small intestine
contrast ultrasonography (b). (a) shows Crohn’s disease stenosis and prestenotic dilation, well deﬁned in (b). Red arrowheads indicate bowel
wall thickness in both panels, white arrows indicate prestenotic dilation in (b).
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Figure 3: Bowel ultrasound in a 22-year-old female with ileocolonic Crohn’s disease. In (a) red arrow indicates enteroenteric ﬁstula (deﬁned
as a hypoechoic track with a hyperechoic content) between diseased ileal loops with bowel wall thickness (red arrowheads). In (b) a small
abscess (white arrowheads identify a roundish anechoic lesions with irregular walls, presenting internal echoes) with ﬁstula (white arrow)
was identiﬁed in the same patient.
thenumberofstenoses.BowelUSwithoralcontrastdetected
at least one stenosis and at least two stenoses in >10% and
>20% more patients, respectively, in comparison with bowel
US without oral contrast agents, resulting in a sensitivity
of approximately 90% for detection of a single stenosis and
>75% for detection of multiple stenoses (Figures 2(a) and
2(b))[ 26, 27].
4.Fistula
Two prospective studies have evaluated the role of US
(without oral contrast) in determining the presence of
internal ﬁstulae (Figure 3(a)) using surgical and surgical-
pathological ﬁndings as the reference standard. In one
study, Gasche et al. reported a sensitivity of 87% and a
speciﬁcity of 90% for bowel US in the detection of internal
ﬁstulae [4]. In the other prospective study, Maconi et al.
determined the accuracy of bowel US and X-ray studies for
detecting internal ﬁstulae to be comparable with a sensitivity
of 71.4% for US and 69.6% for X-ray, and speciﬁcity
of 95.8% for both techniques. Maconi et al. showed also
that the combination of these two techniques signiﬁcantly
improved preoperative diagnostic performance (sensitivity
97.4% and speciﬁcity 90%), with US being more accurate in
detecting enteromesenteric ﬁstulae while X-ray studies were
superior in the diagnosis of enteroenteric ﬁstulae [29]. In
a recent study by Pallotta et al., SICUS identiﬁed ﬁstulae
in 27/28 patients and excluded it in 19/21 patients (96%
sensitivity, 90.5% speciﬁcity) using surgery as gold standard
[30]. In a recent systematic review, Panes and colleagues
evaluated diagnostic accuracy of cross-sectional imaging
techniques (US, CT and MR) for diagnosis of ﬁstulas. These
techniques showed higher accuracy than that of small bowel
follow through (SBFT) [31]. CT and MR enterography4 International Journal of Inﬂammation
showed similar accuracy for the identiﬁcation of extraenteric
complications (sensitivity for both) [32, 33].
5. Abscess
Computed tomography (CT) and magnetic resonance imag-
ing (MRI) are considered to be nonsurgical gold standard
for the diagnosis of CD-related abscesses [31]. However,
bowel US is also considered as a ﬁrst-level procedure mainly
because it is simple to use (Figure 3(b)). Four studies have
prospectively assessed the accuracy of bowel US in the
detection of intraabdominal abscesses, showing a mean
sensitivity and speciﬁcity of 91.5% and 93%, respectively [3,
4, 29, 34]. In these studies, US showed a higher sensitivity in
thedetectionofsuperﬁcialintraperitonealabscesses,whereas
the diagnosis of deep pelvic or retroperitoneal abscesses was
more diﬃcult due to the presence of overlying bowel gas.
Pallotta et al. showed that intraabdominal abscesses were
correctly detected in 10/10 patients and excluded in 37/39
patients (100% sensitivity, 95% speciﬁcity, k = 0.89) by
SICUS [30].
Contrast-enhanced ultrasound (CEUS) can be used to
distinguish abscesses from inﬂammatory inﬁltrates [35].
6. PostoperativeRecurrence
The sensitivity of bowel US in identifying the endoscopic
recurrence after ileocolonic resection has been investigated
in two studies showing 82% sensitivity [6, 36]. The use
of PEG solution increased the sensitivity of ultrasound for
assessing CD recurrence in patients under regular followup
after ileocolonic resection. In our series, SICUS showed a
highsensitivity(92.5%),positivepredictivevalue(94%),and
accuracy (87.5%) for detecting CD recurrence lesions using
ileocolonoscopy as the gold standard [7].
7.CDActivity
The role of bowel US in the assessment of CD activity
remains controversial. The degree of bowel wall thickening
and extent of the thickened bowel wall on US (as an
index of activity in CD) showed a signiﬁcant but weak
direct correlation between these features and clinical and
biochemical parameters [22]. However, a statistically signif-
icant correlation was found between maximum bowel wall
thickness and disease activity score in children and young
adults [37].
Several studies have focused on the vascularity within
the diseased bowel walls, assessed by power-Doppler US, as
a quantitative method for determining CD activity. Three
studies used Doppler US for detection of active disease,
showing that wall thickness and vascularization pattern are
useful for detection of active disease [38–40]. A recent study
evaluating ﬂow of the superior mesenteric artery conﬁrmed
previous observations regarding the correlation between
disease activity and Doppler parameters [41–43].
The eﬀectiveness of intravenous contrast agents in
detection and assessing of bowel US activity of CD, despite
some positive ﬁndings, remains controversial [40, 44–47].
The introduction of the microbubble contrast agents has
enabled US to obtain information regarding the perfusion
behavior of the organs and their diﬀuse or focal diseases.
Enhancement in diﬀerent wall layers can be evaluated
and quantiﬁed in CD and correlates to clinical activity
indices [35]. Migaleddu et al. reported in a prospective
study that contrast-enhanced ultrasound (CEUS) showed
93.5%sensitivity,93.7%speciﬁcity,and93.6overallaccuracy
in detecting inﬂammatory activity, calculated using the
endoscopy/biopsy as gold standard. The linear correlation
coeﬃcient for CEUS versus Crohn’s disease activity index
(CDAI) was 0.74 (P<0.0001) [40]. Ripolles et al. reported
in a prospective study sensitivity and speciﬁcity of 96% and
73%, respectively, in the prediction of moderate or severe
grade for inﬂammation at CEUS using endoscopy as gold
standard [45]. More studies are needed to establish the exact
role of CEUS in the imaging of GI pathology [35].
8. Conclusion
In recent years, several radiological and endoscopic tech-
niques have been developed for the study of the small
bowel. Bowel US has now become the ﬁrst-line imaging
procedure in patients with suspected CD for its early
diagnosis. However, since the procedure is easy to use and
oﬀers good repeatability and accuracy, the most important
indication of bowel US is currently in the followup of
patients known to have CD. CEUS has been introduced
as eﬀective method in the quantitative and qualitative
evaluationofCDinﬂammatoryactivity.Inthiscontext,these
techniques may play a pivotal role in the early detection
of intraabdominal complications, such as strictures, ﬁstulae,
and abscesses, and may be useful in the assessment of activity
and in monitoring the course of disease during medical and
postoperative followup, as a prognostic index of recurrence.
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